Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Experientia Supplementum (2012) is Scopus-indexed (Q1, CiteScore 12). Published by Springer International Publishing.
Checked against the index lists dated .
ISSN 1664-431XVerify ISSN ↗2504-3692Verify ISSN ↗
Publisher: Springer International Publishing
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 22 / 361 | 94th | Q1 |
| Genetics | 25 / 357 | 93rd | Q1 |
| Medicine (miscellaneous) | 32 / 466 | 93rd | Q1 |
| Endocrinology | 11 / 132 | 92nd | Q1 |
| Oncology | 42 / 428 | 90th | Q1 |
| Molecular Biology | 48 / 414 | 88th | Q1 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2026 (also 2021–2022, 2018–2019), best quartile Q1, CiteScore 12.
Experientia Supplementum (2012) is Q1 in Infectious Diseases (rank 22 of 361), Q1 in Genetics (rank 25 of 357) and Q1 in Medicine (miscellaneous) (rank 32 of 466), by CiteScore 2025. It is ranked in 6 subject areas in all.
Experientia Supplementum (2012) is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 12, quartile Q1, 94th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Experientia Supplementum (2012) is published by Springer International Publishing. Its print ISSN is 1664-431X and its online ISSN is 2504-3692.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Experientia Supplementum (2012) has an h-index of 22 and a 2-year mean of 0.27 citations per paper (OpenAlex). Its Scopus CiteScore is 12, quartile Q1. On 2-year citations it ranks #302 of 354 Scopus journals in Infectious Diseases.
Experientia Supplementum (2012) published 26 papers in 2022; its busiest recent year was 2018 with 36. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.